AVE
Avecho Biotechnology Limited
🇦🇺 ASX
📦 LOGISTICS
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
-10.00%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
7
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Avecho Biotechnology Ltd. engages in the development and commercialization of human and animal products through its proprietary drug delivery system. The company is headquartered in Melbourne, Victoria. The firm develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The firm's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The firm's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The firm is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.
📈 Performance
Price History
-97.07%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🍃 Environmental, Social and Governance scores ℹ️
🌳
Environmental Score
44
A measure of an organisations or investment's impact on the natural environment, including factors such as carbon emissions, resource usage, and pollution
⚖️
Governance Score
37
An evaluation of an organisations impact on society, focusing on factors such as employee welfare, diversity and inclusion, community engagement, and product safety and quality.
🤓 Advanced information
Technical Info
💰 Price*
$0.00
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in AVE
7
📊 Total Capital Earnings
$1K
🔃 Average investment frequency
45 weeks
💵 Average investment amount
$431
⏰ Last time a customer invested in AVE
5 days
AVE investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
29%
50k - 100k
14%
Less than 50k
57%
👶 Age of investors
18 - 25
26 - 34
29%
35 - 90
71%
🙋 Legal gender of investors
Female
43%
Male
57%
Pearlers who invest in AVE also invest in...
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
19.63%
📊 Share price
$61.01 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
Commonwealth Bank of Australia engages in the provision of banking and financial services. The company is headquartered in Sydney, New South Wales and currently employs 48,930 full-time employees. The company serves approximately 17 million customers. The firm's segments include Retail Banking Services, Business Banking, Institutional Banking and Markets and New Zealand. Retail Banking Services segment provides banking products and services to personal customers, and banking and advisory services for high-net-worth individuals. Business Banking serves the banking needs of business, corporate and agribusiness customers across the full range of financial service solutions. Institutional Banking and Markets offers a full range of financial services solutions including access to debt capital markets, transaction banking, working capital and risk management. New Zealand includes the banking and funds management businesses operating in New Zealand under the ASB brand.
🙌 Performance (5Yr p.a)
19.81%
📊 Share price
$159.03 AUD
🏦 BANKING
🍃 HIGH ESG SCORE
🌳 ENVIRONMENTAL
⚖️ HIGH GOVERNANCE
📈 HIGH PRICE GROWTH
NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.
🙌 Performance (5Yr p.a)
25.73%
📊 Share price
$47.45 AUD
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
13.23%
📊 Share price
$134.96 AUD
🌏 GLOBAL
🤖 TECHNOLOGY
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
Zelira Therapeutics Ltd. is a bio-pharmaceutical company. The company is headquartered in Perth, Western Australia. The company went IPO on 2003-07-28. The firm is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. The company owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. The company is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription (Rx) business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter (OTC) products. The company has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The firm in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.
🙌 Performance (5Yr p.a)
-18.91%
📊 Share price
$0.64 AUD
📦 LOGISTICS
Want more shares? Try these...
Australian Vintage Ltd. engages in wine making, wine marketing, and vineyard management. The company is headquartered in Adelaide, South Australia and currently employs 459 full-time employees. The Company’s principal activities include wine making, wine marketing, and vineyard management. Its segments include Australia / New Zealand, UK, Europe & Americas, and Asia. Australia / New Zealand segment is engaged in the growing of grapes, manufacturing, sales and marketing of alcoholic wine, non-alcoholic wine and other beverages in Australia, New Zealand and the Pacific through wholesale and retail channels. In addition, the Australia / New Zealand segment sells concentrate and other commercial products to customers globally. UK, Europe & Americas segment is engaged in the packaging, sales and marketing of alcoholic wine, non-alcoholic wine and other beverages in the United Kingdom, Europe & the Americas through wholesale, distributor and retail channels. Asia segment is engaged in the sales and marketing of alcoholic wine, non-alcoholic wine and other beverages in Asia through wholesale channels.
🙌 Performance (5Yr p.a)
-14.72%
📊 Share price
$0.14 AUD
🍔 FOOD PRODUCTS
Auctus Investment Group Ltd. primary focus is to invest into companies and platforms operating in growth sectors. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-08-10. The firm is focused on opportunities across private equity, infrastructure and operating real-estate. The company invests in growth sectors with tailwinds and significant potential to scale. The firm provides access to these private market opportunities via investment funds to wholesale, family office, and institutional investors. The firm focuses on value accretive opportunities that deliver strong shareholder returns over the long term.
🙌 Performance (5Yr p.a)
22.30%
📊 Share price
$0.55 AUD
📈 HIGH PRICE GROWTH
💸 FINANCIALS
AVADA Group Ltd. engages in the provision of traffic management and ancillary services. The company is headquartered in Brisbane, Queensland. The company went IPO on 2021-12-17. The firm operates through four segments: Queensland Traffic Management, New South Wales Traffic Management, Victoria Traffic Management, and New Zealand Traffic Management. Queensland Traffic Management contains entities which operate in the Queensland geography. New South Wales Traffic Management contains entities which operate in the New South Wales geography. Victoria Traffic Management contains entities which operate in the Victorian geography. New Zealand Traffic Management contains entities which operate in the New Zealand geography. Its businesses include Verifact Traffic, A2O Traffic Solutions, D&D Traffic Management, Platinum Traffic Services, Traffic Marshal, Construct Traffic, TRAFFIC MANAGEMENT PEOPLE (TMP) and Linemark Traffic Control.
📊 Share price
$0.49 AUD
🔨 COMMERCIAL SERVICES & SUPPLIES
🕊️
Social Score
41
An assessment of an organisations management practices, board structure, transparency, and accountability, reflecting its commitment to ethical behavior and responsible decision-making.